Shared insight from Rana McKay, MD, and the Oncology Brothers on updated data from PSMAfore and the use of Lutetium-177–PSMA-617 in patients with metastatic castration-resistant prostate cancer.
Stay up to date on practice-changing data in community practice.
AI Predicts Prostate Cancer Prognosis Fairly Across Races
Mack Roach III, MD, discussed a study on artificial intelligence’s generalizability for prostate cancer across racial groups.
Read More
Transforming Prostate Cancer Care Through Personalized Medicine
Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.
Listen
Confronting Prostate Cancer Misinformation in the Digital Age
In an interview, Stacy Loeb, MD, discussed a study analyzing prostate cancer misinformation on social media.
Dizman’s Global Pursuit to Cancer Research and Understanding
In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States.
Expert Panel Addresses 5 Areas of Need in Metastatic Prostate Cancer
Experts developed consensus recommendations through the modified Delphi process for metastatic prostate cancer management during the 2024 US Prostate Cancer Conference.
Nadofaragene Firadenovec Shows Promise in Japanese Patients With BCG-Unresponsive NMIBC
The gene therapy nadofaragene firadenovec demonstrated strong clinical activity in Japanese patients with BCG-unresponsive non–muscle-invasive bladder cancer.